Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension
About this trial
This is an interventional diagnostic trial for Pulmonary Arterial Hypertension focused on measuring Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, PAH, CTEPH, Non-invasive Hemodynamics, Non-invasive Blood Pressure
Eligibility Criteria
Inclusion Criteria: Patient ≥ 18 years of age. The patient must understand and sign informed consent form (ICF). Patients with a confirmed diagnosis or suspected diagnosis of pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) prior to initiation or change in therapy. PAH or CTEPH patients undergoing right heart catheterization (RHC) as part of their standard of care. Exclusion Criteria: BMI < 20 or BMI > 35. Height less than 120 cm. Diagnosis of atrial fibrillation, aortic or mitral valve insufficiency or stenosis, or end-stage renal disease.
Sites / Locations
- Ronald Reagan UCLA Medical Center
Arms of the Study
Arm 1
Experimental
Patients diagnosed with PAH or CTEPH
Patients with a confirmed diagnosis or suspected diagnosis of pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) prior to initiation or change in therapy.